Related references
Note: Only part of the references are listed.Cyclosporine versus Tacrolimus Treated Liver Transplant Recipients with Chronic Hepatitis C: Outcomes Analysis of the UNOS/OPTN Database
W. D. Irish et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Reduced-Dose Tacrolimus with Mycophenolate Mofetil vs. Standard-Dose Tacrolimus in Liver Transplantation: A Randomized Study
K. Boudjema et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Interleukin 2 Receptor Antagonists for Liver Transplant Recipients: A Systematic Review and Meta-Analysis of Controlled Studies
Armin D. Goralczyk et al.
HEPATOLOGY (2011)
Noninvasive Diagnosis of Acute Cellular Rejection in Liver Transplant Recipients: A Proteomic Signature Validated by Enzyme-Linked Immunosorbent Assay
Omar Massoud et al.
LIVER TRANSPLANTATION (2011)
Alemtuzumab Induction in Non-Hepatitis C Positive Liver Transplant Recipients
Josh Levitsky et al.
LIVER TRANSPLANTATION (2011)
Screening of mortality in transplant patients using an assay for immune function
David Berglund et al.
TRANSPLANT IMMUNOLOGY (2011)
A Decade of Experience Using mTor Inhibitors in Liver Transplantation
Jeffrey Campsen et al.
JOURNAL OF TRANSPLANTATION (2011)
Daclizumab induction therapy in liver transplant recipients with renal insufficiency
S. K. Asrani et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma
Andreas A. Schnitzbauer et al.
BMC CANCER (2010)
State of the art on the research for biomarkers allowing individual, tailor-made minimization of immunosuppression
Birgit Sawitzki et al.
CURRENT OPINION IN ORGAN TRANSPLANTATION (2010)
Sirolimus-Based Immunosuppression Is Associated with Increased Survival After Liver Transplantation for Hepatocellular Carcinoma
Christian Toso et al.
HEPATOLOGY (2010)
Use of Sirolimus in Liver Transplant Recipients with Renal Insufficiency: A Systematic Review and Meta-Analysis
Sumeet K. Asrani et al.
HEPATOLOGY (2010)
Study Protocol: A Pilot Study to Determine the Safety and Efficacy of Induction-Therapy, De Novo MPA and Delayed mTOR-Inhibition in Liver Transplant Recipients with Impaired Renal Function. PATRON-Study
Andreas A. Schnitzbauer et al.
BMC NEPHROLOGY (2010)
A therapeutic exploratory study to determine the efficacy and safety of calcineurin-inhibitor-free de-novo immunosuppression after liver transplantation: CILT
Armin D. Goralczyk et al.
BMC SURGERY (2010)
Incidence and Severity of Acute Cellular Rejection in Recipients Undergoing Adult Living Donor or Deceased Donor Liver Transplantation
A. Shaked et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Delayed Introduction of Reduced-Dose Tacrolimus, and Renal Function in Liver Transplantation: The 'ReSpECT' Study
J. M. Neuberger et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Immunosuppression withdrawal improves long-term metabolic parameters, cardiovascular risk factors and renal function in liver transplant patients
Jose A. Pons et al.
CLINICAL TRANSPLANTATION (2009)
How antigen quantity and quality determine T-cell decisions in lymphoid tissue
Huan Zheng et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Impact of Immunosuppression Without Steroids on Rejection and Hepatitis C Virus Evolution After Liver Transplantation: Results of a Prospective Randomized Study
Laura Llado et al.
LIVER TRANSPLANTATION (2008)
Influence of steroids on HCV recurrence after liver transplantation: A prospective study
Marco Vivarelli et al.
JOURNAL OF HEPATOLOGY (2007)
Corticosteroid-free immunosuppression with Daclizumab in HCV+ liver transplant recipients:: 1-year interim results of the HCV-3 study
Goran B. G. Klintmalm et al.
LIVER TRANSPLANTATION (2007)
Immunosuppression with calcineurin inhibitors with respect to the outcome of HCV recurrence after liver transplantation: Results of a meta-analysis
Marina Berenguer et al.
LIVER TRANSPLANTATION (2007)
Assessing relative risks of infection and rejection: A meta-analysis using an immune function assay
Richard J. Kowalski et al.
TRANSPLANTATION (2006)
Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation
RJ Firpi et al.
LIVER TRANSPLANTATION (2006)
T-cell receptor triggering is critically dependent on the dimensions of its peptide-MHC ligand
K Choudhuri et al.
NATURE (2005)
Immunosuppressive drugs for kidney transplantation
PF Halloran
NEW ENGLAND JOURNAL OF MEDICINE (2004)
CD3/CD28 costimulation-induced NF-kappa B activation is mediated by recruitment of protein kinase C-theta, Bcl10, and I kappa B kinase beta to the immunological synapse through CARMA1
DH Wang et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: With particular reference to hepatitis C virus
A Marcos et al.
TRANSPLANTATION (2004)
Steroid-free liver transplantation using rabbit antithymocyte globulin induction: Results of a prospective randomized trial
JD Eason et al.
LIVER TRANSPLANTATION (2001)
Advances in immunology: T-cell function and migration - Two sides of the same coin
UH von Andrian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
